Intellia Therapeutics
NTLA
NTLA
300 hedge funds and large institutions have $1.42B invested in Intellia Therapeutics in 2026 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 127 increasing their positions, 62 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3.58% more ownership
Funds ownership: 89.95% → 93.53% (+3.6%)
3% more funds holding
Funds holding: 291 → 300 (+9)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
300
Holding in Top 10
2
Calls
$60.6M
Puts
$23M
Top Buyers
| 1 | +$25.6M | |
| 2 | +$23.9M | |
| 3 | +$23.3M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$17.8M |
| 5 |
CGH
Contrarius Group Holdings
Hamilton,
Bermuda
|
+$15.3M |
Top Sellers
| 1 | -$15M | |
| 2 | -$10.4M | |
| 3 | -$6.27M | |
| 4 |
Barclays
London,
United Kingdom
|
-$4.64M |
| 5 |
HF
HRT Financial
New York
|
-$3.34M |
